T. Boggon

Molecular Biology · 2002–2012

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 55 citations into it
• Materials Chemistry — 6 citations into it

Whom T. Boggon trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Tony Pawson
2. Randy J. Read
3. J. Stamos
4. G. Murshudov

Who trusts T. Boggon overall

1. C. Yun
2. B. Gumbiner
3. Shang-Gin Wu

Papers from T. Boggon's perspective

Ordered by how strongly the researchers T. Boggon trusts endorse each paper. Same corpus, a different order for every researcher.

1. Improved methods for building protein models in electron density maps and the location of errors in these models.
2. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (Science)
3. Crystallography & NMR system: A new software suite for macromolecular structure determination.
4. The conformational plasticity of protein kinases. (Cell)
5. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (Science)
6. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
7. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
8. Assembly of Cell Regulatory Systems Through Protein Interaction Domains (Science)
9. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers (International Journal of Cancer)
10. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. (Cancer Research)

Their papers

• Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth (2009) — 782 citations
• Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma (2012) — 1,151 citations
• EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. (2005) — 4,065 citations
• Structure and regulation of Src family kinases (2004) — 687 citations
• Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. (2007) — 1,098 citations
• C-Cadherin Ectodomain Structure and Implications for Cell Adhesion Mechanisms (2002) — 695 citations
• Activation of the AXL Kinase Causes Resistance to EGFR-Targeted Therapy in Lung Cancer (2012) — 1,168 citations
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. (2005) — 3,130 citations
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (2004) — 9,841 citations